NO921525D0 - L-alfa-glyserofosforyl-d-myo-inositol for behandling av perifere nervelidelser og hjernelidelser - Google Patents

L-alfa-glyserofosforyl-d-myo-inositol for behandling av perifere nervelidelser og hjernelidelser

Info

Publication number
NO921525D0
NO921525D0 NO1992921525A NO921525A NO921525D0 NO 921525 D0 NO921525 D0 NO 921525D0 NO 1992921525 A NO1992921525 A NO 1992921525A NO 921525 A NO921525 A NO 921525A NO 921525 D0 NO921525 D0 NO 921525D0
Authority
NO
Norway
Prior art keywords
disorders
glycerophosphoryl
myo
treatment
pct
Prior art date
Application number
NO1992921525A
Other languages
English (en)
Other versions
NO179009B (no
NO921525L (no
NO179009C (no
Inventor
Carlo Scolastico
Camillo Maria Francesc Palazzi
Carlo Procida
Original Assignee
Depha Team Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Depha Team Srl filed Critical Depha Team Srl
Publication of NO921525L publication Critical patent/NO921525L/no
Publication of NO921525D0 publication Critical patent/NO921525D0/no
Publication of NO179009B publication Critical patent/NO179009B/no
Publication of NO179009C publication Critical patent/NO179009C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO921525A 1989-10-27 1992-04-21 Analogifremgangsmåte for fremstilling av salter av L-alfa-glyserofosforyl-D-myo-inositol NO179009C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT22173A IT1239474B (it) 1989-10-27 1989-10-27 Composizioni farmaceutiche a base di l-alfa-glicerofosforil-d-myo- inositolo o suoi sali alcalini o alcalino-terrosi per la terapia delleneuropatie periferiche di origine dismetabolica o tossica, e delle cerebropatie su base organica e funzionale
PCT/EP1990/001757 WO1991006301A1 (en) 1989-10-27 1990-10-17 L-alpha-glycerophosphoryl-d-myo-inositol for the treatment of peripheral neuropathies and of cerebropathies

Publications (4)

Publication Number Publication Date
NO921525L NO921525L (no) 1992-04-21
NO921525D0 true NO921525D0 (no) 1992-04-21
NO179009B NO179009B (no) 1996-04-09
NO179009C NO179009C (no) 1996-07-17

Family

ID=11192582

Family Applications (1)

Application Number Title Priority Date Filing Date
NO921525A NO179009C (no) 1989-10-27 1992-04-21 Analogifremgangsmåte for fremstilling av salter av L-alfa-glyserofosforyl-D-myo-inositol

Country Status (14)

Country Link
US (1) US5281586A (no)
EP (1) EP0497906B1 (no)
JP (1) JP3037749B2 (no)
KR (1) KR0176978B1 (no)
AT (1) ATE100713T1 (no)
AU (1) AU645533B2 (no)
CA (1) CA2067755A1 (no)
DE (1) DE69006360T2 (no)
DK (1) DK0497906T3 (no)
ES (1) ES2062570T3 (no)
HU (2) HU210767B (no)
IT (1) IT1239474B (no)
NO (1) NO179009C (no)
WO (1) WO1991006301A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1247093B (it) * 1991-01-22 1994-12-12 Flarer S R L Ora Castellini S Derivati salini del gliceril fosforil mioinositolo ad attivita' terapeutica, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
IT1265647B1 (it) * 1992-11-18 1996-11-22 Farmin Srl Composizione farmaceutiche topiche per le allergie respiratorie
GB9801899D0 (en) * 1998-01-29 1998-03-25 Univ London Neurotrophic properties of ipgs analogues
ATE308548T1 (de) * 2000-11-07 2005-11-15 I R B Istituto Di Ricerche Bio Glycerophosphoinositol-derivate als cytosolic a2 phospholipase modulatoren
JP5670858B2 (ja) * 2011-10-14 2015-02-18 イ．エルレ．ビ．イスティトゥト ディ リチェルケ ビオテクノロジケ ソチエタ ペル アツィオニ サイトゾルのホスホリパーゼのモジュレーターとしてのグリセロホスホイノシトール誘導体

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3239817A1 (de) * 1982-07-06 1984-01-12 Max Planck Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Neue glycerinderivate zur synthese von phospholipiden

Also Published As

Publication number Publication date
ATE100713T1 (de) 1994-02-15
DK0497906T3 (da) 1994-03-21
HU9201267D0 (en) 1992-07-28
IT8922173A1 (it) 1991-04-27
KR920703067A (ko) 1992-12-17
NO179009B (no) 1996-04-09
KR0176978B1 (ko) 1999-03-20
JPH05502861A (ja) 1993-05-20
EP0497906A1 (en) 1992-08-12
EP0497906B1 (en) 1994-01-26
HU210767B (en) 1995-07-28
IT8922173A0 (it) 1989-10-27
IT1239474B (it) 1993-11-02
WO1991006301A1 (en) 1991-05-16
AU6884891A (en) 1991-05-31
CA2067755A1 (en) 1991-04-28
NO921525L (no) 1992-04-21
JP3037749B2 (ja) 2000-05-08
HUT61667A (en) 1993-03-01
NO179009C (no) 1996-07-17
DE69006360D1 (de) 1994-03-10
ES2062570T3 (es) 1994-12-16
AU645533B2 (en) 1994-01-20
DE69006360T2 (de) 1994-05-19
US5281586A (en) 1994-01-25

Similar Documents

Publication Publication Date Title
PT750618E (pt) Derivados de oxazolidinona e composicoes farmaceuticas que os contem
FI961809A (fi) Uudet (R)-5-karbamoyyli-8-fluori-3-N,N-disubstituoitu-amino 3,4-dihydro-2H-1-bentsopyraanit
PT98710A (pt) Processo de preparacao de compostos de indolilo substituidos e de composicoes farmaceuticas que os contem
ATE198708T1 (de) Verwendung von makrolid-verbindungen gegen augenerkrankungen
ATE269066T1 (de) Kombinationstherapie zur prophylaxe und/oder behandlung von gutartiger prostatischer hyperplasie
EP0444196A4 (en) Agent for treatment and prophylaxis of ischemic disease of heart or brain
PT705100E (pt) Guanidinas substituidas terapeuticas
ES2182903T3 (es) Derivados heterociclicos utiles en el tratamiento de enfermedades alergicas o reumaticas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
YU47116B (sh) Postupak za dobijanje novih n-supstituisanih benzimidazolskih derivata
PH25313A (en) Carboxylic acid derivatives, pharmaceutical compositions containing them
DK1032556T3 (da) Farmaceutisk aktive forbindelser og anvendelsesfremgangsmåder
FI951511A (fi) IL-10:n käyttö insuliinista riippuvan diabetes mellituksen ennaltaestoon tai hoitoon
NO921525D0 (no) L-alfa-glyserofosforyl-d-myo-inositol for behandling av perifere nervelidelser og hjernelidelser
RU94040886A (ru) Применение производных мелатонина для лечения нарушений сна, фармацевтическая композиция
GB9020861D0 (en) Pharmaceutical compositions
DE69429856D1 (de) Substituierte caprolactame und deren derivate verwendbar zur behandlung der hiv-krankheit
EP0594795A4 (en) MICHELLAMINES USEFUL AS ANTIVIRAL AGENTS, COMPOSITION AND METHOD OF TREATMENT.
DE69221725D1 (de) Amylin oder amylinanaloga enthaltende zusammensetzung, welche auch wahlweise insulin enthält, zur behandlung von anorexie und verwandten zuständen
MC1930A1 (fr) Produit antiviral
ATE216891T1 (de) Verwendung von immunosuppressiva zur behandlung der schizophrenie
MX9300205A (es) Compuestos policiclicos disubstituidos y composicion farmaceutica que los contiene.
MX9300203A (es) Compuestos policiclicos disubstituidos y composicion farmaceutica que los contiene.
ATE193206T1 (de) Zusammensetzung zur behandlung oder vorbeugung von herpes
DE69023006D1 (de) Verfahren zur behandlung von thrombocytopenie und dafür geeignete pharmazeutische zusammensetzungen.
GB9015774D0 (en) Novel treatment

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN APRIL 2001